LEO 32731 - A Phase I Study in Healthy Subjects
NCT02514694
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis Vulgaris
Interventions
DRUG:
LEO32731
OTHER:
Placebo
Sponsor
LEO Pharma